이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Sinopharm Group 배당금
배당금 기준 확인 5/6
Sinopharm Group 수익으로 충분히 충당되는 현재 수익률 3.98% 보유한 배당금 지급 회사입니다.
주요 정보
5.2%
배당 수익률
31%
지급 비율
| 업계 평균 수익률 | 4.3% |
| 다음 배당금 지급일 | n/a |
| 전 배당일 | n/a |
| 주당 배당금 | HK$0.956 |
| 주당 순이익 | HK$2.85 |
| 3년 후 배당 수익률 예측 | 6.5% |
최근 배당금 업데이트
Recent updates
The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet
Jul 27
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956
Jun 16Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?
May 13Is Sinopharm Group (HKG:1099) A Risky Investment?
Apr 22Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital
Mar 21Should You Think About Buying Sinopharm Group Co. Ltd. (HKG:1099) Now?
Mar 06Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 29% Discount?
Jan 31Is Sinopharm Group (HKG:1099) A Risky Investment?
Jan 15There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding
Dec 31Returns On Capital Signal Tricky Times Ahead For Sinopharm Group (HKG:1099)
Nov 29If EPS Growth Is Important To You, Sinopharm Group (HKG:1099) Presents An Opportunity
Nov 14Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 28% Discount?
Nov 01Should You Investigate Sinopharm Group Co. Ltd. (HKG:1099) At HK$22.45?
Sep 20Is Sinopharm Group (HKG:1099) Using Too Much Debt?
Sep 05Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled
Aug 18Are Sinopharm Group Co. Ltd. (HKG:1099) Investors Paying Above The Intrinsic Value?
Aug 02Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly
Jun 01Sinopharm Group's (HKG:1099) Returns Have Hit A Wall
Apr 26These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well
Feb 27Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger
Jan 19Is Sinopharm Group (HKG:1099) A Risky Investment?
Nov 18Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down
Oct 03Is Sinopharm Group (HKG:1099) Using Too Much Debt?
Jul 31Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)
Jul 10Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement
Jun 05We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt
Apr 11A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)
Mar 21Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns
Mar 03Is Sinopharm Group (HKG:1099) Using Too Much Debt?
Jan 09Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price
Dec 19Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled
Dec 01These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well
Sep 23A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)
Sep 10Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing
Aug 28Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84
Jun 13Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly
Jun 06Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value
May 24Sinopharm Group's (HKG:1099) Returns Have Hit A Wall
May 11Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?
Mar 20We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt
Mar 05You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend
Feb 18
Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?
Feb 03Should You Use Sinopharm Group's (HKG:1099) Statutory Earnings To Analyse It?
Jan 19At HK$19.00, Is It Time To Put Sinopharm Group Co., Ltd. (HKG:1099) On Your Watch List?
Jan 06What Type Of Shareholders Make Up Sinopharm Group Co., Ltd.'s (HKG:1099) Share Registry?
Dec 25Read This Before Buying Sinopharm Group Co., Ltd. (HKG:1099) Shares
Dec 15We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt
Dec 04결제의 안정성과 성장
배당금 데이터 가져오기
안정적인 배당: 1099 의 주당 배당금은 지난 10 년 동안 안정적이었습니다.
배당금 증가: 1099 의 배당금 지급은 지난 10 년 동안 증가했습니다.
시장 대비 배당 수익률
| Sinopharm Group 시장 대비 배당 수익률 |
|---|
| 세그먼트 | 배당 수익률 |
|---|---|
| 회사 (1099) | 5.2% |
| 시장 하위 25% (HK) | 3.5% |
| 시장 상위 25% (HK) | 8.2% |
| 업계 평균 (Healthcare) | 4.3% |
| 3년 후 애널리스트 예측 (1099) | 6.5% |
주목할만한 배당금: 1099 의 배당금( 3.98% )은 Hong Kong 시장에서 배당금 지급자의 하위 25%( 3.2% )보다 높습니다. 3.2% ).
고배당: 1099 의 배당금( 3.98% )은 Hong Kong 시장에서 배당금 지급자의 상위 25% 7.75% ).
주주에 대한 수익 배당금
수익 보장: 합리적으로 낮은 지불 비율 ( 30.6% )로 1099 의 배당금 지급은 수익으로 충분히 충당됩니다.
주주에 대한 현금 배당금
현금 흐름 범위: 합리적으로 낮은 현금 지급 비율 ( 31.8% )로 1099 의 배당금 지급은 현금 흐름으로 잘 충당됩니다.